PE20020520A1 - USE OF ANTIPROGESTINES FOR PROPHYLAXIS AND THE TREATMENT OF HORMONE-DEPENDENT DISEASES - Google Patents
USE OF ANTIPROGESTINES FOR PROPHYLAXIS AND THE TREATMENT OF HORMONE-DEPENDENT DISEASESInfo
- Publication number
- PE20020520A1 PE20020520A1 PE2001001025A PE2001001025A PE20020520A1 PE 20020520 A1 PE20020520 A1 PE 20020520A1 PE 2001001025 A PE2001001025 A PE 2001001025A PE 2001001025 A PE2001001025 A PE 2001001025A PE 20020520 A1 PE20020520 A1 PE 20020520A1
- Authority
- PE
- Peru
- Prior art keywords
- hormone
- treatment
- antiprogestines
- prophylaxis
- dependent diseases
- Prior art date
Links
Abstract
SE REFIERE AL USO DE ANTIPROGESTINA 11ß-(4-ACETILFENIL)-17ß-HIDROXI-17O-(1,1,2,2,2-PENTAFLUOROETIL)-ESTRA-4,9-DIEN-3-ONA DE FORMULA I PARA LA PREPARACION DE UN MEDICAMENTO PARA EL TRATAMIENTO O PREVENCION DE UNA ENFERMEDAD DEPENDIENTE DE HORMONAS COMO CANCER DE MAMA; UTILIZANDOSE 50mg POR VIA ORAL. TAMBIEN SE REFIERE A UNA COMPOSICION QUE COMPRENDE ANTIPROGESTINA 11ß-(4-ACETILFENIL)-17ß-HIDROXI-17O-(1,1,2,2,2-PENTAFLUOROETIL)-ESTRA-4,9-DIEN-3-ONA Y UN ANTIESTROGENOREFERS TO THE USE OF ANTIPROGESTIN 11ß- (4-ACETYLPHENIL) -17ß-HYDROXY-17O- (1,1,2,2,2-PENTAFLUOROETHYL) -ESTRA-4,9-DIEN-3-ONA FORMULA I FOR PREPARATION OF A MEDICATION FOR THE TREATMENT OR PREVENTION OF A HORMONE-DEPENDENT DISEASE SUCH AS BREAST CANCER; USING 50mg BY ORAL ROUTE. ALSO REFERS TO A COMPOSITION INCLUDING ANTIPROGESTIN 11ß- (4-ACETYLPHENYL) -17ß-HYDROXY-17O- (1,1,2,2,2-PENTAFLUOROETHYL) -ESTRA-4,9-DIEN-3-ONA AND A ANTIESTROGEN
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00250341 | 2000-10-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20020520A1 true PE20020520A1 (en) | 2002-06-15 |
Family
ID=34072454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2001001025A PE20020520A1 (en) | 2000-10-18 | 2001-10-16 | USE OF ANTIPROGESTINES FOR PROPHYLAXIS AND THE TREATMENT OF HORMONE-DEPENDENT DISEASES |
Country Status (8)
Country | Link |
---|---|
AR (1) | AR032371A1 (en) |
EA (1) | EA007529B1 (en) |
EC (1) | ECSP034605A (en) |
PE (1) | PE20020520A1 (en) |
RS (1) | RS50389B (en) |
UA (1) | UA75615C2 (en) |
UY (1) | UY26965A1 (en) |
ZA (1) | ZA200303793B (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19706061A1 (en) * | 1997-02-07 | 1998-08-13 | Schering Ag | Anti-gestagen effective steroids with fluorinated 17alpha alkyl chain |
-
2001
- 2001-10-12 UY UY26965A patent/UY26965A1/en not_active Application Discontinuation
- 2001-10-16 PE PE2001001025A patent/PE20020520A1/en not_active Application Discontinuation
- 2001-10-17 AR ARP010104867A patent/AR032371A1/en unknown
- 2001-10-17 UA UA2003054404A patent/UA75615C2/en unknown
- 2001-10-17 RS YUP-301/03A patent/RS50389B/en unknown
- 2001-10-17 EA EA200300480A patent/EA007529B1/en not_active IP Right Cessation
-
2003
- 2003-05-14 EC ECSP034605 patent/ECSP034605A/en unknown
- 2003-05-15 ZA ZA200303793A patent/ZA200303793B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA007529B1 (en) | 2006-10-27 |
ECSP034605A (en) | 2003-06-25 |
UY26965A1 (en) | 2002-06-20 |
RS50389B (en) | 2009-12-31 |
EA200300480A1 (en) | 2003-10-30 |
UA75615C2 (en) | 2006-05-15 |
ZA200303793B (en) | 2004-08-16 |
YU30103A (en) | 2006-08-17 |
AR032371A1 (en) | 2003-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9911482A (en) | Compound, pharmaceutical composition, use of the compound, and, processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound | |
BR0308429A (en) | Monocyclic Aroylpyridinones as Anti-Inflammatory Agents | |
ECSP034916A (en) | SUBSTITUTED OXAZOLIDINONES FOR COMBINATION THERAPY | |
ECSP034732A (en) | DERIVATIVE OF PHENETHANOLAMINE FOR THE TREATMENT OF RESPIRATORY DISEASES | |
UY27740A1 (en) | NEW COMPOUNDS | |
SV2003000697A (en) | BETA3-ADRENERGIC RECEIVER AGONISTS AND USES OF THE SAME REF. PC11008 / 700016 / BB | |
BRPI0418251B8 (en) | phosphonates, monophosphonamidates, bisphosphonamidates, and pharmaceutical composition comprising them | |
AR023423A1 (en) | ADAMANTAN DERIVATIVES, PROCEDURES FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION, PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITION, AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF MEDICINES | |
UY27329A1 (en) | SHAMPOOS WITH BEHENYL ALCOHOL | |
AR022008A1 (en) | A COMPOSITION OF CONTROLLED GALANTAMINE RELEASE, A PROCESS FOR THE PREPARATION OF THE SAME, AND THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
PA8591701A1 (en) | PIRROLOPIRIMIDINE DERIVATIVES | |
BR9911488A (en) | Compound, use of it, pharmaceutical composition, and processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound | |
CR7743A (en) | NEW OXAZOL AND TIAZOL COMPOUNDS AS INHIBITOR OF THE TRANSFORMING GROWTH FACTOR (TGF) | |
BRPI0108395B8 (en) | pyrrolopyrimidinone derivatives, preparation and use processes | |
AR048336A1 (en) | HYDROCLORIDE OF (4- (5-AMINOMETIL-2-FLUORO-PHENYL) -PIPERIDIN-1-IL) - (4-BROMO-3-METHYL-5-PROPOXI-TIOFEN-2-IL) -METANONE AS AN INHIBITOR OF THE MASTOCYT TRIPTASE | |
BRPI0518781A2 (en) | pharmaceutical formulation, process for preparing a pharmaceutical formulation, and use of a compound | |
BR0309342A (en) | Compound, pharmaceutical composition, use of a compound, and method of treating or prophylaxis of human diseases or conditions. | |
BRPI0414428A (en) | pharmaceutical compositions | |
BR0114665A (en) | Use of antiprogestins for prophylaxis and treatment of hormone dependent diseases | |
ES2177671T3 (en) | ENTERZINETIC BENZAMIDE. | |
BR9912816A (en) | Therapeutic composition based on flavonoids, intended for use in the treatment of tumors by cytotoxic agents | |
AR035064A1 (en) | 3- (1-METHYL-3-INDOLIL) -4- (1-METHYL-6-NITRO-3-INDOLIL) -1H-PIRROL-2,5-DIONA, AMORPHALLY, PROCESSES TO PREPARE IT, PHARMACEUTICAL COMPOSITION THAT THE UNDERSTAND AND USE OF SUCH COMPOUND IN THE MANUFACTURE OF MEDICINES | |
ES2150404T1 (en) | PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDE AND NITOZOXANIDE. | |
PE20020520A1 (en) | USE OF ANTIPROGESTINES FOR PROPHYLAXIS AND THE TREATMENT OF HORMONE-DEPENDENT DISEASES | |
BRPI0410707A (en) | A composition comprising pure progesterone receptor antagonists and antiestrogens for the prophylaxis and treatment of hormone dependent diseases. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |